Medisafe 1 Technologies in Negotiations to Acquire Breakthrough Dental Implant Technology

News provided by

Medisafe 1 Technologies Corp.

Jun 09, 2011, 04:15 ET

JERUSALEM, June 9, 2011 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has entered negotiations to acquire a breakthrough technology in the dental implant industry.

The technology promotes healing, and enables real-time functional occlusion, improving the connection between bone and implant and thereby increasing dental implantation success rates.

"Acquisition of dental technology is intended to increase Medisafe 1 Technologies' range of products and bring added value to our shareholders," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We intend to further update our shareholders in the coming weeks regarding this new potential acquisition."

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

    Contact:

    Jacob Elhadad
    CEO
    +972-524440000
    [email protected]

SOURCE Medisafe 1 Technologies Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED